At this fall’s annual Scientific Meeting of the Sexual Medical Society of North America (SMSNA), Dr. Michael Zahalsky will present findings from his work on biologics therapy for erectile dysfunction and Peyronie’s Disease (the development of fibrous scar tissue in the penis).
Over the past few years, Dr. Zahalsky put together a world-renowned team of urologists to assist in the research and education of biological products in urology. The team, known as UroCellZ, is a clinical research group made up of 20 Sexual Dysfunction experts from around the United States.
“As I personally continue to see the success of our biologics research and treatment for sexual dysfunction, I want to shout from the rooftops how exciting this news is for a very large segment of our population,” says Dr. Zahalsky. “When we get to share our studies with other medical experts from around the world, it’s especially gratifying, educating peers and potentially changing the lives of patients.”
UroCellZ Research has also teamed up with Atlanta, Georgia-based Vivex Biomedical, an authority on biological products. Previously, the company’s products have been used to treat orthopedic, spine, wound and soft tissue injuries. However, the UroCellZ team believes that these same products and techniques can also be used to help millions of people suffering from urological conditions—especially male and female sexual dysfunction.
In order to better understand how sexual dysfunction may be affecting your patients, consider attending this meeting—or at least following its progress on social media.
